Henry Schein, Inc. (NASDAQ:HSIC - Free Report) - Equities researchers at Barrington Research dropped their FY2026 earnings per share (EPS) estimates for Henry Schein in a research report issued to clients and investors on Thursday, January 30th. Barrington Research analyst M. Petusky now forecasts that the company will post earnings per share of $5.25 for the year, down from their previous forecast of $5.80. Barrington Research currently has a "Outperform" rating and a $90.00 target price on the stock. The consensus estimate for Henry Schein's current full-year earnings is $4.76 per share.
A number of other research firms also recently weighed in on HSIC. Bank of America raised shares of Henry Schein from an "underperform" rating to a "buy" rating and upped their price target for the stock from $69.00 to $84.00 in a research note on Monday, January 6th. Jefferies Financial Group raised their price target on Henry Schein from $77.00 to $80.00 and gave the stock a "hold" rating in a research note on Thursday, January 23rd. Mizuho started coverage on Henry Schein in a research note on Wednesday, December 4th. They issued a "neutral" rating and a $75.00 price target for the company. Finally, StockNews.com upgraded Henry Schein from a "sell" rating to a "hold" rating in a report on Thursday, November 7th. Seven equities research analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $80.10.
Read Our Latest Report on HSIC
Henry Schein Stock Down 2.5 %
Shares of HSIC stock traded down $2.06 during trading on Monday, hitting $79.85. 1,148,702 shares of the company were exchanged, compared to its average volume of 1,435,854. The firm has a market capitalization of $9.96 billion, a price-to-earnings ratio of 32.86, a P/E/G ratio of 2.21 and a beta of 0.91. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. The business's 50-day simple moving average is $73.66 and its 200 day simple moving average is $71.73. Henry Schein has a twelve month low of $63.67 and a twelve month high of $82.63.
Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share for the quarter, beating analysts' consensus estimates of $1.17 by $0.05. The company had revenue of $3.17 billion for the quarter, compared to the consensus estimate of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The firm's quarterly revenue was up .4% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.32 EPS.
Institutional Investors Weigh In On Henry Schein
Several hedge funds have recently modified their holdings of the business. Raymond James Financial Inc. acquired a new position in Henry Schein during the 4th quarter valued at $34,720,000. Proficio Capital Partners LLC bought a new position in shares of Henry Schein during the 4th quarter worth about $943,000. Keybank National Association OH raised its position in shares of Henry Schein by 7.4% during the fourth quarter. Keybank National Association OH now owns 15,718 shares of the company's stock valued at $1,088,000 after buying an additional 1,089 shares during the last quarter. Charles Schwab Investment Management Inc. raised its position in shares of Henry Schein by 1.4% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,191,677 shares of the company's stock valued at $82,464,000 after buying an additional 16,616 shares during the last quarter. Finally, LGT Group Foundation lifted its stake in shares of Henry Schein by 9.0% in the fourth quarter. LGT Group Foundation now owns 289,568 shares of the company's stock valued at $20,038,000 after buying an additional 23,965 shares during the period. 96.62% of the stock is owned by institutional investors.
Insider Buying and Selling
In other Henry Schein news, COO Michael S. Ettinger sold 12,240 shares of the firm's stock in a transaction that occurred on Monday, November 18th. The stock was sold at an average price of $75.00, for a total value of $918,000.00. Following the sale, the chief operating officer now owns 87,706 shares of the company's stock, valued at $6,577,950. This trade represents a 12.25 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. 1.14% of the stock is owned by insiders.
About Henry Schein
(
Get Free Report)
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Further Reading

Before you consider Henry Schein, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Henry Schein wasn't on the list.
While Henry Schein currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.